• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Hyperlipidaemia

Hyperlipidaemia

9780199543502
221.06 zł
198.95 zł Save 22.11 zł Tax included
Lowest price within 30 days before promotion: 198.95 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In the last decade, advances in the understanding of lipoprotein and lipid metabolism have developed enormously. This has resulted in a detailed knowledge of the mechanisms underlying the primary and secondary dyslipidaemias. Furthermore, the role of lipoproteins in atherogenesis is increasingly understood at the cellular and molecular level. In this book, the scale of the problem of cardiovascular disease (CVD) is described together with the possibilities for prevention. The pathophysiology of lipid and lipoproteins provide a background to the understanding of the primary and secondary dyslipidaemias and the mechanism of action of the different drug classes.A practical approach to therapy is provided including diet, lifestyle, and therapeutic approaches. Common clinical problems are addressed and the book looks to the future, principally in relation to new therapeutic targets. This book provides the basis for the translation of clinical trial science into everyday clinical practice for the benefit of the individual patient.
Product Details
OUP Oxford
86223
9780199543502
9780199543502

Data sheet

Publication date
2012
Issue number
1
Cover
paperback
Pages count
168
Dimensions (mm)
100 x 180
Weight (g)
146
  • Epidemiology of cardiovascular disease: the scale of the problem; Lipids, lipoproteins and atherogenesis; Risk estimation systems in clinical use: SCORE, HeartScore, Framingham, PROCAM, ASSIGN and QRISK; Primary dyslipidaemias; Secondary dyslipidemias; Diet and lifestyle; Pharmacological therapy: Statins; Pharmacological therapy: Non-Statin Drugs; Combination therapy for the management of hyperlipidaemia; Recent lipid-lowering trials in perspective: Implications for therapy; Vascular imaging; Common problems in lipid management;
Comments (0)